WILLOW LABORATORIES
CM
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATE
Specific issues
Support for coverage and reimbursement for diabetes prevention and wellness technologies; patient safety; support for PBM reform and corporate governance.
Support for increased Medicare and Medicaid coverage and reimbursement for diabetes prevention technologies
corporate governance and transparency
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →